Advanced Enzyme Technologies has concluded its open market share buyback, successfully utilizing 99.99% of the allocated Rs 69.70 crore. The company repurchased over 2.41 million shares, effectively reducing its total equity capital from 111.97 million to 109.56 million shares.
Advanced Enzyme Technologies Concludes Share Buyback Program
Total Utilization: Rs 69.70 Crore | Shares Repurchased: 2,410,906
Reader Takeaway: The buyback successfully reduced the equity base, potentially improving earnings per share for remaining shareholders.
What just happened
Advanced Enzyme Technologies Ltd officially concluded its share buyback program on October 30, 2026. Initiated on August 14, 2026, the company successfully utilized Rs 69.69 crore of the allocated Rs 69.70 crore, achieving a 99.99% utilization rate. The program was executed via the open market mechanism on the stock exchanges.
Why this matters
The buyback resulted in the repurchase of 2,410,906 shares at an average price of Rs 289.09 per share. As a direct result, the total number of outstanding equity shares of the company has decreased from 111,976,150 (as of August 8, 2026) to 109,565,244 (as of October 30, 2026). Reducing the equity base is a method companies use to return surplus cash to shareholders and can potentially improve financial metrics like Earnings Per Share (EPS).
Extinguishment Status
The company has confirmed the regulatory compliance of the share extinguishment process. A total of 1,713,324 shares were extinguished by September 2026. The remaining 697,582 shares, acquired throughout October 2026, are currently undergoing the formal extinguishment process in line with SEBI Buyback Regulations.
What to track next
Investors should monitor the upcoming quarterly financial filings to assess the impact of this reduced share count on the company’s per-share profitability and capital efficiency metrics.